CytomX Therapeutics Stock (NASDAQ: CTMX) stock price, news, charts, stock research, profile.
You can purchase shares of CytomX Therapeutics (NASDAQ:CTMX) through any online brokerage.
Other companies in CytomX Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), Skye Bioscience (NASDAQ:SKYE), bluebird bio (NASDAQ:BLUE), OS Therapies (AMEX:OSTX) and Adicet Bio (NASDAQ:ACET).
CytomX Therapeutics has a consensus price target of $5.70.
The stock price for CytomX Therapeutics (NASDAQ: CTMX) is $1.1 last updated December 23, 2024 at 8:07 AM EST.
There are no upcoming dividends for CytomX Therapeutics.
CytomX Therapeutics’s Q4 earnings are confirmed for Monday, March 10, 2025.
There is no upcoming split for CytomX Therapeutics.
CytomX Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.